A detailed history of Innovis Asset Management LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Innovis Asset Management LLC holds 22,581 shares of DVAX stock, worth $271,197. This represents 0.13% of its overall portfolio holdings.

Number of Shares
22,581
Previous 15,328 47.32%
Holding current value
$271,197
Previous $198 Million 68.41%
% of portfolio
0.13%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$12.64 - $14.99 $91,677 - $108,722
7,253 Added 47.32%
22,581 $334 Million
Q2 2023

Aug 03, 2023

BUY
$9.85 - $13.17 $150,980 - $201,869
15,328 New
15,328 $198 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.52B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Innovis Asset Management LLC Portfolio

Follow Innovis Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Innovis Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Innovis Asset Management LLC with notifications on news.